[{"address1": "401 Professional Drive", "address2": "Suite 260", "city": "Gaithersburg", "state": "MD", "zip": "20879", "country": "United States", "phone": "(240) 403-4212", "website": "https://www.shuttlepharma.com", "industry": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers . The company is based in Gaithersburg, Maryland.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Dr. Anatoly  Dritschilo M.D.", "age": 79, "title": "Co-Founder, CEO & Chairman of the Board", "yearBorn": 1944, "fiscalYear": 2023, "totalPay": 399175, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter Dale Dritschilo M.B.A., M.D.", "age": 54, "title": "President & COO", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 314012, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Milton  Brown CSC, M.D., Ph.D.", "age": 58, "title": "Co-Founder & Director", "yearBorn": 1965, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.66, "open": 1.61, "dayLow": 1.61, "dayHigh": 1.7, "regularMarketPreviousClose": 1.66, "regularMarketOpen": 1.61, "regularMarketDayLow": 1.61, "regularMarketDayHigh": 1.7, "beta": 1.039, "volume": 64595, "regularMarketVolume": 64595, "averageVolume": 550099, "averageVolume10days": 243010, "averageDailyVolume10Day": 243010, "bid": 1.56, "ask": 1.68, "bidSize": 100, "askSize": 100, "marketCap": 3607659, "fiftyTwoWeekLow": 1.28, "fiftyTwoWeekHigh": 5.44, "fiftyDayAverage": 2.51038, "twoHundredDayAverage": 3.200075, "currency": "USD", "enterpriseValue": 2424423, "floatShares": 1336928, "sharesOutstanding": 2226950, "sharesShort": 8459, "sharesShortPriorMonth": 19567, "sharesShortPreviousMonthDate": 1722384000, "dateShortInterest": 1724976000, "sharesPercentSharesOut": 0.004, "heldPercentInsiders": 0.43172002, "heldPercentInstitutions": 0.01725, "shortRatio": 0.21, "shortPercentOfFloat": 0.0066000004, "bookValue": 0.381, "priceToBook": 4.2519684, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -7195501, "trailingEps": -3.44, "enterpriseToEbitda": -0.422, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "SHPH", "underlyingSymbol": "SHPH", "shortName": "Shuttle Pharmaceuticals Holding", "longName": "Shuttle Pharmaceuticals Holdings, Inc.", "firstTradeDateEpochUtc": 1661952600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "7d533843-75d5-319f-b923-9ea3e624e2b7", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.62, "recommendationKey": "none", "totalCash": 2338589, "totalCashPerShare": 1.05, "ebitda": -5742737, "totalDebt": 1155352, "quickRatio": 1.694, "currentRatio": 1.795, "debtToEquity": 144.161, "returnOnAssets": -0.61689, "returnOnEquity": -1.86001, "freeCashflow": -2485025, "operatingCashflow": -5235533, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-20"}]